Standardisation of Costs

Siegel, 1997, Pharmacoeconomics, 11, 159, 10.2165/00019053-199711020-00005

Haycox, 1997, Br J Clin Pharmacol, 43, 451, 10.1046/j.1365-2125.1997.00575.x

Drummond, 1993, Int J Technol Assess Health Care, 9, 26, 10.1017/S0266462300003007

Mason, 1997, Pharmacoeconomics, 11, 503, 10.2165/00019053-199711060-00001

Langley, 1996, Pharmacoeconomics, 9, 341, 10.2165/00019053-199609040-00007

Torrance, 1996, Pharmacoeconomics, 9, 535, 10.2165/00019053-199609060-00008

Jacobs, 1995, Pharmacoeconomics, 8, 182, 10.2165/00019053-199508030-00002

Rovira, 1995, Pharmacoeconomics, 8, 245, 10.2165/00019053-199508030-00007

Jacobs, 1996, Health Econ, 5, 525, 10.1002/(SICI)1099-1050(199611)5:6<525::AID-HEC233>3.0.CO;2-E

Goeree, 1999, Pharmacoeconomics, 15, 561, 10.2165/00019053-199915060-00004

Brouwer, 1998, Int J Technol Assess Health Care, 14, 505, 10.1017/S026646230001148X

Johannesson, 1997, Pharmacoeconomics, 11, 385, 10.2165/00019053-199711050-00001

Koopmanschap, 1995, J Health Econ, 14, 171, 10.1016/0167-6296(94)00044-5

Koopmanschap, 1992, Soc Sci Med, 34, 1005, 10.1016/0277-9536(92)90131-9

Groeneveld, 1996, Medisch Contact, 27, 919

Mason, 1995, Health Econ, 4, 85, 10.1002/hec.4730040202

Siegel, 1996, JAMA, 276, 1339, 10.1001/jama.1996.03540160061034

Jacobs, 1999, Pharmacoeconomics, 15, 551, 10.2165/00019053-199915060-00003